Your browser doesn't support javascript.
loading
Therapeutic inhibition of ferroptosis in neurodegenerative disease.
Ryan, Sean K; Ugalde, Cathryn L; Rolland, Anne-Sophie; Skidmore, John; Devos, David; Hammond, Timothy R.
  • Ryan SK; Sanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
  • Ugalde CL; The ALBORADA Drug Discovery Institute, University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0AH, UK.
  • Rolland AS; Department of Medical Pharmacology, Expert Center of Parkinson's Disease, ALS, and Neurogenetics, University of Lille, LilNCog, Lille Neuroscience and Cognition, INSERM UMR S1172, CHU de Lille, LICEND, COEN, Center, NS-PARK Network, France.
  • Skidmore J; The ALBORADA Drug Discovery Institute, University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0AH, UK.
  • Devos D; Department of Medical Pharmacology, Expert Center of Parkinson's Disease, ALS, and Neurogenetics, University of Lille, LilNCog, Lille Neuroscience and Cognition, INSERM UMR S1172, CHU de Lille, LICEND, COEN, Center, NS-PARK Network, France.
  • Hammond TR; Sanofi, Rare and Neurologic Diseases, Cambridge, MA, USA. Electronic address: Timothy.Hammond@sanofi.com.
Trends Pharmacol Sci ; 44(10): 674-688, 2023 10.
Article en En | MEDLINE | ID: mdl-37657967

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Ferroptosis Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Ferroptosis Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article